絞り込み

16645

広告

EVALUATING THE PRESCRIPTION OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS OR RECEPTOR BLOCKERS IN PATIENTS WITH DIABETES IN JORDAN.

著者 Mayyas F , Bataineh W , Jarab A
Endocr Pract.2017 Aug 17 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (9view , 0users)

Full Text Sources

Medical

Miscellaneous

The angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) are guideline-recommended agents to prevent development and progression of nephropathy and cardiovascular diseases in diabetic Mellitus (DM). The aim of this study was to evaluate the prescription of ACEIs/ARBs in DM patients with guideline indications.
PMID: 28816537 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード